Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Comparing ketamine delivery methods for postoperative pain management in orthopedic surgery

Official title: Analgesic Efficacy of Intravenous Ketamine as a Continuous Infusion vs PCA in the Management of Acute Postoperative Pain in Major Orthopedic Surgery: A Randomized Clinical Trial

Run by Universidad de Antioquia · NCT06774274 · Data updated 2026-11-12

This study is testing whether giving ketamine through an IV or a patient-controlled pump works better for managing pain after major orthopedic surgery in adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorUniversidad de Antioquia
Academic / other
Locations1 site (Medellín, Antioquia)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedMarch 30, 2026
Study endsJune 15, 2027
Registry record updatedApril 11, 2025
Trial IDNCT06774274 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old scheduled for elective major orthopedic surgery.

Probably not a fit

Patients with active cardiac conditions, cognitive impairments, or those requiring continuous regional anesthetic techniques may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of intravenous ketamine administered as a continuous infusion versus a patient-controlled analgesia (PCA) pump for managing postoperative pain in adults undergoing major orthopedic surgery. Participants will be randomly assigned to receive either method, and their pain levels and opioid consumption will be monitored over the first 24 hours post-surgery. The study seeks to determine which method provides better pain control and reduces the need for opioids, addressing a critical aspect of postoperative care.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies that minimize opioid use after major orthopedic surgeries.

How similar studies have gone: Previous studies have shown promising results for ketamine in postoperative pain management, suggesting that this approach may be effective, though the specific comparison of delivery methods is less commonly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over 18 years of age
* Elective major orthopedic surgery.
* ASA (American Association of Anesthesiology) classification 1, 2 or 3.

Exclusion Criteria:

* Patients with a diagnosis of perioperative kidney injury or hepatic failure
* Patients with active cardiac conditions
* Patients with any cognitive impairment that disables the patient from operating the PCA pump or impedes the postoperative interview
* Patients with scheduled ICU admission with invasive ventilatory support
* Patients with known hypersensitivity to opioid medications
* Patients with past medical history of severe adverse reactions to opioids or ketamine.
* Pregnant patients
* Patients undergoing continuous regional anesthetic techniques including peripheral nerve catheters or continuous epidural catheters
* Patient refusal to participate in the study

Where it's running

  • St. Vincent's Foundation University Hospital
    Medellín, Antioquia, Colombia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.